Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Summary by BizToc
The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

4 Articles

The Seattle TimesThe Seattle Times
Lean Left

Another heart drug fails, shocking cardiologists

Novartis announced Friday that its experimental drug, pelacarsen, widely assumed to be the vanguard of a new era in preventing heart attacks, strokes and cardiovascular deaths, had failed.

·Seattle, United States
Read Full Article
El DiarioEl Diario
Reposted by
eldiariodechihuahua.mxeldiariodechihuahua.mx
Center

Another Heart Drug Fails, to the Surprise of Cardiologists

Doctors hoped that the drug, which was being tested in an extensive clinical trial by Novartis, would become a powerful new tool to fight heart disease.

Read Full Article
BizTocBizToc

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BizToc broke the news on Saturday, September 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Seattle icon

Seattle

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal